Open-Label Steroid Reduction Study of Adalimumab With Methotrexate in Patients With Active Rheumatoid Arthritis

Part of paid clinical trials in North Chicago, Illinois.

Sponsor
Abbott
Study ID
NCT00233558
Phase
PHASE4
Status
Terminated

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

Study Details

The purpose of the study is to evaluate the clinical efficacy of scheduled versus free reduction of steroid treatment in patients with active RA treated with adalimumab + MTX

Key Dates

Start date
Jun 30, 2005
Status verified
Apr 2007

Study Design

Enrollment
160 participants
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Primary Outcome Measure

Corticoid reduction and DAS 28

Locations (1)

FacilityCityStateZIPSite coordinators
Global Medical Information - AbbottNorth ChicagoIllinois60064-

Find similar trials in North Chicago, IL

By condition
Rheumatoid arthritis
By specialty
RheumatologyAutoimmune diseaseMusculoskeletal disorders
By research site
Global Medical Information - Abbott· North Chicago, IL

Related Studies